1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow Hematoma: new trials by email Literature Review of Hematoma trials Research Report on Hematoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Tolerability of PF-05230907 in Intracerebral Hemorrhage PF-05230907 - Intracerebral Hemorrhage | Phase 1 | Terminated | Pfizer | 21 | 2016-11-01 | 2019-04-17 |
Cerebral Hemorrhage (1) · Hemorrhage (1)
Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Intracranial Hemorrhages (1) · Nervous System Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Vascular Diseases (1)
PF-05230907 (1)
Pfizer (1)
Canada (1) · Spain (1) · United Kingdom (1) · United States (1)
2015 (1)